In cellular metabolism, the Krebs Cycle, also called Tricarboxylic Acid (TCA), is regarded as one of the main pathways. It oxidizes various metabolites such as fatty acids, carbohydrates, and amino acids, which contain acetyl groups. The list includes carbohydrates, amino acids, and fatty acids.
BioVision provides a wider range of assays for the measurement of different enzymes, cofactors, and metabolites that play a role in the glycolytic pathway and Krebs cycle.
- Unique assays
- Homogeneous, non-radioactive assays
- Validated: using mammalian cells, tissues, and biological fluids
- Economical: 100 assays; compatible with High Throughput Screening
- Convenient: quick protocols (1–2 hours); minimal sample preparation
Figure: Succinate Standard Curve (a). Measurement of Succinate levels in rat liver (40 µg), kidney (40 µg) and muscle (40 µg), jurkat cell lysate (200 µg) and white wine (4 µl, wine sample was diluted 1:1 with 0.5 M Tris HCl, pH 8.0). Assays were performed following the kit K649 protocol.
About BioVision Incorporated
BioVision, Inc., is a privately held Life Science company headquartered in the beautiful San Francisco Bay Area.
BioVision develops and offers a wide variety of products including assay kits, antibodies, recombinant proteins & enzymes, and other innovative research tools for studying Apoptosis, Metabolism, Cell Proliferation, Cellular Stress, Cell Damage and Repair, Diabetes, Obesity and Metabolic Syndrome, Stem Cell Biology, Gene Regulation, Signal Transduction, etc. BioVision's products are currently being sold in more than 60 countries worldwide.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.